Chemotherapy for advanced pancreatic cancer with combined usage of gemcitabine and GSK3beta-inhibiting medicines
Phase 1
Recruiting
- Conditions
- advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000005095
- Lead Sponsor
- 1)Multidisciplinary Cancer Center,Kanazawa Medical University Hospital 2)Department of Surgical Oncology, Kanazawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) A patient who has a past history of hypersensitivity to the medicines used. 2) A pregnant woman, a woman of possible pregnancy, or a lactating woman 3) Miscellaneous patients who are judged inadequate for enrollment by an attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method